Satellos Bioscience Inc. (TSX:MSCL)
Canada
· Delayed Price · Currency is CAD 10.41
+0.57 (5.79%)
Apr 28, 2026, 3:59 PM EST
Satellos Bioscience Employees
As of December 31, 2025, Satellos Bioscience had 21 total employees, including 18 full-time and 3 part-time employees. The number of employees increased by 4 or 23.53% compared to the previous year.
Employees
21
Change (1Y)
4
Growth (1Y)
23.53%
Revenue / Employee
n/a
Profits / Employee
-1.71M CAD
Market Cap
216.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21 | 4 | 23.53% |
| Dec 31, 2024 | 17 | 1 | 6.25% |
| Dec 31, 2023 | 16 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Helix BioPharma | 7 |
| Eupraxia Pharmaceuticals | 49 |
| Sernova Biotherapeutics | 8 |
| Medicenna Therapeutics | 18 |
| BriaCell Therapeutics | 16 |
Satellos Bioscience News
- 19 days ago - Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference - GlobeNewsWire
- 4 weeks ago - MSLE: Analyst Sets $11 Price Target for Satellos Bioscience - GuruFocus
- 4 weeks ago - MSLE: HC Wainwright & Co. Raises Price Target for Satellos Bioscience | MSLE Stock News - GuruFocus
- 4 weeks ago - Satellos Bioscience: 2025 Financial Performance - AlphaStreet
- 4 weeks ago - Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - Benzinga
- 4 weeks ago - Satellos Reports 2025 Financial Results and Highlights Recent Company Progress - GlobeNewsWire
- 2 months ago - Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference - Business Wire
- 2 months ago - Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy - Business Wire